Estimation of transforming growth factor-beta 1 as a marker of renal injury in type II diabetes mellitus

Saudi Medical Journal

Volumn 28, Issue 4, 2007, Pages 519-523

  Ibrahim, Salwa ^a,b   Rashed, Laila ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b NONE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CREATININE; GLYCOSYLATED HEMOGLOBIN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; KIDNEY INJURY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; URINARY EXCRETION;

ALBUMINURIA; BIOLOGICAL MARKERS; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; TRANSFORMING GROWTH FACTOR BETA1;

EID: 34447255425     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Raptis A, Viberti G. Pathogenesis of diabetic nephropathy. Exp. Clin. Endoainol Diabetes 2001; 109: S424-S437.
2. Paczek L, Kropiewnicka. HE, Senatorski G, Bardomiejczyk I. [Urine TGF-beta 1 concentration in patients with type II diabetes mellitus - prognostic values]. Pol Arch Med Wewn 2002; 108: 745-752.
3. Blobe Q, Lodish M, Schimannt A. Role of TGF-β1 in human diseases. N Engl J Med 2000; 4: 1350-1358.
4. Chen S, Hong SW, Iglesias-de la Cruz MC, Isono M, Casaretto A, Ziyadeh FN. The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy. Ren Fail 2001; 23: 471-481.
5. Houlihan C, Akdeniz A, Tsalamandris C. Urinary TGF-β1 excretion in patients with hypertension, type II DM and elevated albumin excretion rate: Effects of angiotensin receptor blockade and sodium restriction. Diabetes Care 2002; 25: 1072-1077.
6. Bordin L, Ceal M, Gambro G et al. Glycosaminoglycan therapy prevents TGF-β over expression and pathologic changes in renal tissue of long-term diabetic rats. J Am Soc Nephrol 2001; 12: 2324-2336.
7. Sharma K, Ziyadeh FN, Alzaliabi B, McGowan TA, Kapoor S, Kurnik BR, et al. Increased renal production of TGF-β1 in patients with type II DM. Diabetes 1997; 46: 854-859.
8. Koop JB, Factor VM, Mozes M, Nagy P, Sanderson N, Bottinger EP, et al. Transgenic mice with measured plasma levels of TGF-β1 develop progressive renal disease. Lab Invest 1996; 74: 991-1003
9. Mogyorosi Z, Ziyadeh N. What is the role of decorine in diabetic kidney disease. Nephrol Dial Transplant 1999; 14: 1078-1081.
10. Nakamura T, Fukui M, Ebihara I, Osada S, Nagaoka I, Tomino Y, et al. mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 1993; 42: 450-456.
11. Hellmich B, Schellner M, Schatz H, Pfeiffer A. Activation of transforming growth factor-betal in diabetic kidney disease. Metabolism 2000; 49: 353-359.
12. Azar ST Salti I, Zantout MS, Major S. Alteration in plasma transforming growth factor beta in normoalbuminuric type 1 and type 2 diabetic patients. J Clin Endocrinol Metabolism 2000; 12: 4680-4682.
13. Leehey DJ, Singh AK, Alavi N, Singh R. Role of angiotensin II in diabetic nephropathy. Kidney Int Suppl 2000; 77: S93-98.
14. Iwano M, Atsushi K, Nishino T et al. Quantification of glomerular TGF-β1 mRNA in patients with diabetes mellitus. Kidney Int 1996; 49: 1120-1126.
15. Di Landro C, Naso G, Bordin F. The effect of metabolic control on development and progression of diabetic nephropathy. Nepbrol Dial Transplant 1998; 13: 3543.
16. Hoffman B, Sharma K, Ziyadeh F. Potential role of TGF-β1 in diabetic nephropathy. Miner Electrolyte Metab 1998; 24: 190-196.
17. Li B, Khanna A, Sharma V, Singh T, Suthanthiran M, August P. TGF-β1 DNA polymorphisms, protein levels and blood pressure. Hypertension 1999; 33: 271-275.
18. Korpinen E, Groop PH, Fagerudd JA, Teppo AM, Akerblom HK, Vaarala O. Increased secretion ofTGF-beta1 by peripheral blood mononuclear cells from patients with Type 1 diabetes mellitus with diabetic nephropathy. Diabet Med 2001; 18: 121-125.
19. Scaglione R, Argano C, Parrinello G, Colomba D, Di Chiara T, Ferrante A, et al. Relationship between transforming growth factor beta1 and progression of hypertensive renal disease. J Hum Hypertens 2002; 16: 641-645.
20. Steffoni S, Ciancilolo G, Donati G. Low serum TGF-β1 level is a risk factor for atherosclerosis in ESRD patients. Kidney Int 2002; 61: 324-335.
21. Esmatjes E, Flores L, Lario S, Claria J, Cases A, Inigo P, et al. Smoking increases serum levels of transforming growth factor-beta in diabetic patients. Diabetes Care 1999; 22: 1915-1916.